Risks and limits of Helicobacter Training

The concept of 'Helicobacter training' (e.g., via diet or probiotics) lacks robust scientific evidence. H. pylori is a bacterium linked to gastritis, ulcers, and gastric cancer, but many carriers remain asymptomatic. Current guidelines do not support microbiome-based 'training' to eradicate H. pylori. Risks include delaying necessary antibiotic therapy and promoting antibiotic resistance. Limits: microbiome tests are not diagnostic, show high day-to-day variability, and cannot replace clinical testing. If H. pylori is suspected, standard medical evaluation and, if indicated, guideline-based triple or quadruple therapy are recommended. Consumer tests may provide general insights but are not actionable for treatment decisions.